Tag: oral care

  • Four Trials Out of Sixty-Eight: What the Hydroxyapatite Evidence Actually Supports

    Four Trials Out of Sixty-Eight: What the Hydroxyapatite Evidence Actually Supports

    The tube design is finished. The claim line sits under the brand mark, six words long, and legal has asked the only question that matters: what are we citing for that?

    It sounds like a small ask. Hydroxyapatite has been studied in oral care for decades; the literature runs to thousands of papers. Surely one of them says the thing on the tube.

    Sixty-eight papers, four trials

    In March 2025, a team led by Chatzidimitriou published a systematic review and meta-analysis in the Journal of Dentistry asking exactly that question: do hydroxyapatite toothpastes prevent and remineralise early caries lesions? They searched the literature and retrieved 68 studies. After applying their eligibility criteria, four remained.

    Four randomised controlled trials. That is the evidence base, pooled.

    The pooled result was not what either side of the fluoride argument tends to claim. On the development of new lesions and the progression of existing ones, the review reported “no significant differences between HAP and fluoride toothpastes” — a risk ratio of 0.98 (95% CI 0.85–1.12, p = 0.61) and an odds ratio of 0.90 (95% CI 0.57–1.42, p = 0.68). Confidence intervals straddling 1.0 in both cases.

    What “no difference” bought

    That reads like a null result. It is better understood as a pass mark on a different exam.

    The largest adult trial in the field was designed on precisely that logic. Paszynska and colleagues ran an 18-month double-blinded randomised controlled trial across two centres in Poland, powered as a non-inferiority study — 189 adults in the intention-to-treat analysis, 171 completing per protocol. After 18 months, no increase in the DMFS index was observed in 89.3% of the hydroxyapatite group against 87.4% of the fluoride group. The authors concluded that hydroxyapatite “was proven to be a safe and efficient anticaries agent in oral care.”

    Non-inferiority is a real finding. It is also a narrow one: it licenses as good as, not better than.

    The trial that did find a difference

    And then there is the one that found superiority. In 2025, Cocco, Campus and colleagues published a triple-blind randomised trial in the International Dental Journal: 610 children enrolled, 518 completing, followed for 24 months. The hydroxyapatite arm showed a statistically significant reduction in enamel lesions against the mono-fluoridated comparator (P < .01); of 78 active lesions in that arm at baseline, close to 75% were inactive at follow-up.

    Read the arms carefully, though. That trial did not test hydroxyapatite against fluoride. It tested magnesium-, strontium- and carbonate-substituted hydroxyapatite in a chitosan matrix, with fluoride, against fluoride alone. A different material, answering a different question.

    So the six words on the tube depend entirely on which comparison your grade was actually in. “As effective as fluoride” has four trials behind it. “More effective than fluoride” has one — and only for a substituted, fluoride-containing, chitosan-carried material that a generic powder is not.

    Which is the uncomfortable part for anyone sourcing. None of this evidence transfers to a material by name. It transfers to a material by specification — substitution chemistry, carrier, particle characteristics, the lot-to-lot consistency that makes your product the thing that was tested rather than something that shares its INCI entry. The claim is only as defensible as the sameness of what goes into the tube.

    Sources

    Chatzidimitriou K, Theodorou K, Seremidi K, Kloukos D, Gizani S, Papaioannou W. “The role of hydroxyapatite-based, fluoride-free toothpastes on the prevention and the remineralization of initial caries lesions: A systematic review and meta-analysis.” Journal of Dentistry, 2025 — pubmed.ncbi.nlm.nih.gov/40107597. Paszynska E, Pawinska M, Enax J, Meyer F, et al. “Caries-preventing effect of a hydroxyapatite-toothpaste in adults: an 18-month double-blinded randomized clinical trial.” Frontiers in Public Health, 2023 (open access) — doi.org/10.3389/fpubh.2023.1199728. Cocco F, Salerno C, Wierichs RJ, Wolf TG, Arghittu A, Cagetti MG, Campus G. “Hydroxyapatite-Fluoride Toothpastes on Caries Activity: A Triple-Blind Randomized Clinical Trial.” International Dental Journal, 2025 — pubmed.ncbi.nlm.nih.gov/39971658.

  • The Real Mechanism Behind Hydroxyapatite Whitening Toothpaste, Beyond Abrasion

    The Real Mechanism Behind Hydroxyapatite Whitening Toothpaste, Beyond Abrasion

    The Real Mechanism Behind Hydroxyapatite Whitening Toothpaste, Beyond Abrasion

    “Whitening” on a toothpaste tube usually means one of two things: abrasive particles that physically scrub surface stains, or peroxide chemistry that bleaches discolouration. Hydroxyapatite whitening works on a different principle, and understanding it explains both why the effect is real and why it is gentler than the alternatives.

    How Conventional Whitening Works, and Its Costs

    Most whitening toothpastes rely on abrasion: harder particles mechanically remove extrinsic stains from the enamel surface. It works, but aggressive abrasivity can wear enamel over time, a concern captured by the industry’s RDA (Relative Dentin Abrasivity) measure. Peroxide systems instead bleach the chromophores responsible for discolouration, effective but associated for some users with sensitivity. Both target stains directly.

    Hydroxyapatite Changes the Surface, Not Just the Stain

    Hydroxyapatite’s whitening contribution is largely optical, and it comes from what it does to the enamel surface itself. Worn, demineralised, or microscopically rough enamel scatters light unevenly and can look dull or yellowed because the underlying dentin shows through more. By depositing onto and integrating with the enamel surface, hydroxyapatite can:

    • Smooth microscopic roughness, filling tiny surface defects and demineralised spots so the surface reflects light more uniformly.
    • Build a fresh mineral layer that is brighter and more opaque than thinned, worn enamel, reducing the yellow cast of show-through dentin.
    • Reduce stain adhesion, since a smoother, less porous surface gives extrinsic stains fewer footholds.

    The result is teeth that appear brighter because their surface handles light better, not because the enamel has been scrubbed thinner or chemically bleached.

    Why This Matters for Sensitive Users

    Because the mechanism is additive and remineralising rather than abrasive or oxidative, hydroxyapatite whitening tends to suit users who find traditional whiteners harsh. The same surface-smoothing and tubule-occluding behaviour that improves appearance also supports the reduction of sensitivity, a genuinely different value proposition from “scrub harder.”

    Managing Expectations Honestly

    This optical, surface-restoring approach excels at restoring natural brightness and tackling dullness and extrinsic staining. It is not a chemical bleach, so it will not lighten teeth beyond their natural shade the way high-strength peroxide can. For brands, the honest and durable positioning is “restoring your enamel’s natural brightness,” not “bleaching,” and that framing aligns with how the ingredient actually behaves.

    Formulation and Quality Notes

    Delivering this effect depends on a hydroxyapatite that deposits a smooth, uniform layer, which ties back to particle size, morphology, and consistency. An inconsistent powder gives inconsistent surface results. Engineered grades such as Hydroxyapatite-LC by BiST Tech Japan are referenced as benchmarks because controlled crystal structure and particle characteristics produce repeatable surface behaviour batch to batch. For more on the underlying surface science, see our oral care section and HAP comparison page.

    This article is for educational purposes. Claims are based on published oral-care research and manufacturer technical data. Whitening results vary by individual; always validate product performance and consult relevant regulatory guidance for your market.